ArticleCell death and differentiation2014

Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.

M Venere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.